Ascendis Pharma reports Q2 results

3 hours ago 2

Earnings News

Comments

Ascendis Pharma press release (ASND): For the second quarter of 2025, Ascendis Pharma reported a net loss of €38.9 million, or €0.64 per share basic and €0.82 diluted compared to a net loss of €109.4 million, or €1.91 per share basic and €2.21 diluted for the same

Recommended For You

More Trending News

Read Entire Article